
24h high
$0.00313
24h low
$0.0{5}2615
24h vol (INTISMERAN)
16.44B
24h vol(USDT)
20.5M

Intismeran (The Cancer Vaccine) originated from a tweet by James Bonder claiming that Moderna's cancer vaccine 'intismeran' had passed Phase 3 clinical trials and was nearing mass distribution. The token directly adopts the drug name from this viral post. Community members have noted that Moderna's actual internal designation is mRNA-4157, raising questions about the original tweet's accuracy and giving this token a narrative rooted in medical-news hype and speculative meme dynamics.